- Home
- PDFS vs RXRX Comparison
PDFS vs RXRX Comparison
Compare PDFS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDFS | RXRX |
|---|---|---|
| Founded | 1992 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PDFS | RXRX |
|---|---|---|
| Price | $65.90 | $3.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $39.67 | $7.50 |
| AVG Volume (30 Days) | 730.6K | ★ 20.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $22.13 | $12.11 |
| Revenue Next Year | $18.92 | $82.52 |
| P/E Ratio | $548.04 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $18.19 | $2.77 |
| 52 Week High | $66.98 | $7.18 |
Technical Indicators
Market Signals| Indicator | PDFS | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.79 | 48.89 |
| Support Level | $25.86 | $2.88 |
| Resistance Level | N/A | $4.01 |
| Average True Range (ATR) | 4.02 | 0.27 |
| MACD | 0.64 | -0.02 |
| Stochastic Oscillator | 91.60 | 25.69 |
Price Performance
Historical ComparisonAbout PDFS PDF Solutions Inc.
PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.